84 related articles for article (PubMed ID: 20347160)
1. Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities.
Tironi-Farinati C; Loidl CF; Boccoli J; Parma Y; Fernandez-Miyakawa ME; Goldstein J
J Neuroimmunol; 2010 May; 222(1-2):48-61. PubMed ID: 20347160
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains.
Boccoli J; Loidl CF; Lopez-Costa JJ; Creydt VP; Ibarra C; Goldstein J
Brain Res; 2008 Sep; 1230():320-33. PubMed ID: 18675791
[TBL] [Abstract][Full Text] [Related]
3. Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study.
Goldstein J; Loidl CF; Creydt VP; Boccoli J; Ibarra C
Brain Res; 2007 Aug; 1161():106-15. PubMed ID: 17610852
[TBL] [Abstract][Full Text] [Related]
4. Subchronic dermal application of N,N-diethyl m-toluamide (DEET) and permethrin to adult rats, alone or in combination, causes diffuse neuronal cell death and cytoskeletal abnormalities in the cerebral cortex and the hippocampus, and Purkinje neuron loss in the cerebellum.
Abdel-Rahman A; Shetty AK; Abou-Donia MB
Exp Neurol; 2001 Nov; 172(1):153-71. PubMed ID: 11681848
[TBL] [Abstract][Full Text] [Related]
5. Silencing of Bak ameliorates apoptosis of human proximal tubular epithelial cells by Escherichia coli-derived Shiga toxin 2.
Wilson C; Foster GH; Bitzan M
Infection; 2005 Oct; 33(5-6):362-7. PubMed ID: 16258868
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions.
Semmler A; Okulla T; Sastre M; Dumitrescu-Ozimek L; Heneka MT
J Chem Neuroanat; 2005 Oct; 30(2-3):144-57. PubMed ID: 16122904
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal administration of Shiga toxin 2 induced neuronal alterations and reduced the expression levels of aquaporin 1 and aquaporin 4 in rat brain.
Lucero MS; Mirarchi F; Goldstein J; Silberstein C
Microb Pathog; 2012 Aug; 53(2):87-94. PubMed ID: 22610042
[TBL] [Abstract][Full Text] [Related]
8. Thalamic involvement in patients with neurologic impairment due to Shiga toxin 2.
Meuth SG; Göbel K; Kanyshkova T; Ehling P; Ritter MA; Schwindt W; Bielaszewska M; Lebiedz P; Coulon P; Herrmann AM; Storck W; Kohmann D; Müthing J; Pavenstädt H; Kuhlmann T; Karch H; Peters G; Budde T; Wiendl H; Pape HC
Ann Neurol; 2013 Mar; 73(3):419-29. PubMed ID: 23424019
[TBL] [Abstract][Full Text] [Related]
9. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.
Marcato P; Mulvey G; Read RJ; Vander Helm K ; Nation PN; Armstrong GD
J Infect Dis; 2001 Feb; 183(3):435-43. PubMed ID: 11133375
[TBL] [Abstract][Full Text] [Related]
10. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
11. A glucosylceramide synthase inhibitor protects rats against the cytotoxic effects of shiga toxin 2.
Silberstein C; Lucero MS; Zotta E; Copeland DP; Lingyun L; Repetto HA; Ibarra C
Pediatr Res; 2011 May; 69(5 Pt 1):390-4. PubMed ID: 21270676
[TBL] [Abstract][Full Text] [Related]
12. [Astrocyte activation and Bcl-2 protein expression induced by lipopolysaccharide in mouse brain].
Deng XH; Liu S; Cai WJ; Lei DL; Luo XG
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):401-7. PubMed ID: 17611314
[TBL] [Abstract][Full Text] [Related]
13. Newly generated dentate granule cells from epileptic rats exhibit elongated hilar basal dendrites that align along GFAP-immunolabeled processes.
Shapiro LA; Korn MJ; Ribak CE
Neuroscience; 2005; 136(3):823-31. PubMed ID: 16344154
[TBL] [Abstract][Full Text] [Related]
14. Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.
Pohlenz JF; Winter KR; Dean-Nystrom EA
Infect Immun; 2005 Jan; 73(1):612-6. PubMed ID: 15618202
[TBL] [Abstract][Full Text] [Related]
15. Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53.
Joo CK; Choi JS; Ko HW; Park KY; Sohn S; Chun MH; Oh YJ; Gwag BJ
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):713-20. PubMed ID: 10067975
[TBL] [Abstract][Full Text] [Related]
16. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.
Obata F; Tohyama K; Bonev AD; Kolling GL; Keepers TR; Gross LK; Nelson MT; Sato S; Obrig TG
J Infect Dis; 2008 Nov; 198(9):1398-406. PubMed ID: 18754742
[TBL] [Abstract][Full Text] [Related]
18. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.
Takahashi K; Funata N; Ikuta F; Sato S
J Neuroinflammation; 2008 Mar; 5():11. PubMed ID: 18355415
[TBL] [Abstract][Full Text] [Related]
19. Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35).
Stepanichev MY; Zdobnova IM; Yakovlev AA; Onufriev MV; Lazareva NA; Zarubenko II; Gulyaeva NV
J Neurosci Res; 2003 Jan; 71(1):110-20. PubMed ID: 12478619
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte-neuron vulnerability to prenatal stress in the adult rat brain.
Barros VG; Duhalde-Vega M; Caltana L; Brusco A; Antonelli MC
J Neurosci Res; 2006 Apr; 83(5):787-800. PubMed ID: 16493669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
